IRWD : Analysis & Opinions
December 23, 2014Ironwood reported a loss of $0.30 per share in the third quarter of 2014, narrower than the year-ago loss of $0.51 and the ...
January 7, 2013Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. (IPXL), a specialty pharmaceutical company, recently ...
December 31, 2012Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients suffering ...
February 10, 2010The initial public offering market has recently hit a few bumps, as investors become nervous about the overall stock market.